12/18/2024
4:15 PM | Iovance Biotherapeutics (Issuer)
Puri Raj K. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2024
4:16 PM | Iovance Biotherapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
12/02/2024
4:25 PM | Iovance Biotherapeutics (Issuer)
Puri Raj K. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/21/2024
4:15 PM | Iovance Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
3:50 PM | Iovance Biotherapeutics (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
| Form SC 13G/A | |
11/12/2024
6:11 PM | Iovance Biotherapeutics (Subject)
Maynard Ryan D (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/07/2024
8:03 PM | Iovance Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
11/07/2024
4:15 PM | Iovance Biotherapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/18/2024
7:38 AM | Iovance Biotherapeutics (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
10/16/2024
5:30 PM | BILINSKY IGOR (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/16/2024
5:32 PM | GRAF FINCKENSTEIN FRIEDRICH (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/16/2024
5:33 PM | Iovance Biotherapeutics (Issuer)
Vogt Frederick G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
6:52 PM | Bellemin Jean-Marc (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
6:53 PM | BILINSKY IGOR (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
6:54 PM | GRAF FINCKENSTEIN FRIEDRICH (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
6:56 PM | Iovance Biotherapeutics (Issuer)
Vogt Frederick G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2024
4:16 PM | Iovance Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
4:10 PM | Iovance Biotherapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/17/2024
7:00 PM | BILINSKY IGOR (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2024
7:01 PM | GRAF FINCKENSTEIN FRIEDRICH (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2024
7:01 PM | Iovance Biotherapeutics (Issuer)
Vogt Frederick G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2024
6:30 AM | Iovance Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/13/2024
5:00 PM | Dukes Iain D. (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
5:00 PM | Iovance Biotherapeutics (Issuer)
Maynard Ryan D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
5:01 PM | Iovance Biotherapeutics (Issuer)
WEISER MICHAEL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
5:02 PM | Iovance Biotherapeutics (Issuer)
YARNO WENDY L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
5:03 PM | Countouriotis Athena (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
4:15 PM | Iovance Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/05/2024
7:07 PM | GRAF FINCKENSTEIN FRIEDRICH (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
7:04 PM | Iovance Biotherapeutics (Issuer)
Vogt Frederick G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
7:05 PM | BILINSKY IGOR (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
7:01 AM | Iovance Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/17/2024
4:15 PM | Iovance Biotherapeutics (Filer)
| Form DEFA14A | |
05/01/2024
4:05 PM | Iovance Biotherapeutics (Filer)
| Form ARS | |
04/29/2024
4:06 PM | Iovance Biotherapeutics (Filer)
| Form DEF 14A | |
04/29/2024
4:07 PM | Iovance Biotherapeutics (Filer)
| Form DEFA14A | |
04/17/2024
6:07 PM | BILINSKY IGOR (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2024
6:07 PM | GRAF FINCKENSTEIN FRIEDRICH (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2024
6:08 PM | Iovance Biotherapeutics (Issuer)
Vogt Frederick G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/29/2024
4:00 PM | Iovance Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2024
5:19 PM | Iovance Biotherapeutics (Issuer)
Vogt Frederick G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad) It’s here. This is the moment we’ve been waiting for.
The next 3-6 months in crypto will be absolutely life-changing for those who are prepared.
Why? Because altcoin prices are about to explode. >> Register for the Workshop Now |
03/06/2024
5:20 PM | GRAF FINCKENSTEIN FRIEDRICH (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
5:17 PM | BILINSKY IGOR (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
4:58 PM | Iovance Biotherapeutics (Issuer)
YARNO WENDY L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
4:50 PM | Countouriotis Athena (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
4:51 PM | Bellemin Jean-Marc (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
4:52 PM | BILINSKY IGOR (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
7:00 AM | Iovance Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/01/2024
6:09 PM | Iovance Biotherapeutics (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
| Form SC 13G | |
02/29/2024
6:30 AM | Iovance Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/28/2024
3:05 PM | Iovance Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/21/2024
3:44 PM | Iovance Biotherapeutics (Filer)
| Form 424B5 | |
02/20/2024
6:52 PM | Iovance Biotherapeutics (Issuer)
MCPEAK MERRILL A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2024
4:23 PM | Iovance Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/20/2024
5:03 AM | Iovance Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
5:16 AM | Iovance Biotherapeutics (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SC 13G/A | |
02/09/2024
4:40 PM | Iovance Biotherapeutics (Subject)
MHR FUND MANAGEMENT LLC (Filed by)
| Form SC 13G/A | |
01/25/2024
9:49 AM | Iovance Biotherapeutics (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/18/2024
5:07 PM | BILINSKY IGOR (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/18/2024
5:09 PM | GRAF FINCKENSTEIN FRIEDRICH (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/18/2024
5:09 PM | Iovance Biotherapeutics (Issuer)
Vogt Frederick G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
4:03 PM | Iovance Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/27/2023
4:00 PM | Iovance Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Free IOVA Stock Alerts